Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.75B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 3 |
Procter & Gamble
PG
|
+$980M |
| 4 |
Apple
AAPL
|
+$894M |
| 5 |
Amazon
AMZN
|
+$815M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$806M |
| 2 |
Palo Alto Networks
PANW
|
+$726M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$654M |
| 4 |
Toronto Dominion Bank
TD
|
+$494M |
| 5 |
Enbridge
ENB
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.1% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.8% |
| 4 | Healthcare | 7.3% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5151
John Hancock US High Dividend ETF
JHDV
$11.1M
| $170K | ﹤0.01% |
5,619
-21,106
| -79% | -$603K |
|
5152
CVR Partners
UAN
$1.31B
| $170K | ﹤0.01% |
2,596
-1,615
| -38% | -$121K |
|
|
NAGE
5153
Niagen Bioscience
NAGE
$239M
| $170K | ﹤0.01% |
119,042
+34,448
| +41% | +$48K |
|
5154
Adaptive Biotechnologies
ADPT
$3.94B
| $169K | ﹤0.01% |
34,485
+32,115
| +1,355% | +$147K |
|
|
PHK
5155
PIMCO High Income Fund
PHK
$858M
| $169K | ﹤0.01% |
33,947
-1,318
| -4% | -$5.98K |
|
|
SACH
5156
Sachem Capital Corp
SACH
$37.9M
| $169K | ﹤0.01% |
45,124
+324
| +0.7% | +$1.16K |
|
5157
CEVA Inc
CEVA
$937M
| $168K | ﹤0.01% |
7,353
+4,141
| +129% | +$85.3K |
|
5158
Equinox Gold
EQX
$13.5B
| $168K | ﹤0.01% |
34,410
-15,786
| -31% | -$74.9K |
|
5159
Xtrackers Low Beta High Yield Bond ETF
HYDW
$67.8M
| $168K | ﹤0.01% |
3,644
+2,644
| +264% | +$119K |
|
|
MBCN
5160
DELISTED
Middlefield Banc Corp
MBCN
| $168K | ﹤0.01% |
5,210
+3,840
| +280% | +$111K |
|
|
BCIC
5161
BCP Investment Corp
BCIC
$94.7M
| $168K | ﹤0.01% |
9,269
+120
| +1% | +$2.1K |
|
5162
Southland Holdings
SLND
$32.1M
| $168K | ﹤0.01% |
32,555
+1,154
| +4% | +$6.63K |
|
|
BRAG
5163
Bragg Gaming Group
BRAG
$47.2M
| $167K | ﹤0.01% |
32,974
+718
| +2% | +$3.47K |
|
5164
Conduent
CNDT
$236M
| $167K | ﹤0.01% |
46,016
+16,107
| +54% | +$50.9K |
|
5165
iShares MSCI Japan Value ETF
EWJV
$754M
| $167K | ﹤0.01% |
5,715
-11,206
| -66% | -$319K |
|
5166
Nuveen Global High Income Fund
JGH
$352M
| $167K | ﹤0.01% |
13,720
-6,171
| -31% | -$69.4K |
|
|
MRNS
5167
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $167K | ﹤0.01% |
15,364
+8,507
| +124% | +$63.8K |
|
5168
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$134M
| $166K | ﹤0.01% |
4,071
-2,413
| -37% | -$91.5K |
|
5169
Vera Therapeutics
VERA
$2.28B
| $166K | ﹤0.01% |
10,790
+5,199
| +93% | +$66K |
|
5170
Daktronics
DAKT
$986M
| $165K | ﹤0.01% |
19,404
+5,762
| +42% | +$55K |
|
5171
SelectQuote
SLQT
$129M
| $165K | ﹤0.01% |
120,082
+9,567
| +9% | +$12.5K |
|
5172
First Trust Alternative Absolute Return Strategy ETF
FAAR
$196M
| $164K | ﹤0.01% |
5,989
+725
| +14% | +$20.2K |
|
5173
Hippo Holdings
HIPO
$872M
| $164K | ﹤0.01% |
17,919
+2,056
| +13% | +$17.1K |
|
5174
Liquidity Services
LQDT
$1.36B
| $164K | ﹤0.01% |
9,517
+2,101
| +28% | +$40K |
|
5175
Vanda Pharmaceuticals
VNDA
$316M
| $164K | ﹤0.01% |
38,785
-35,024
| -47% | -$141K |
|
Similar funds
Royal Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, Royal Bank of Canada held 7,942 positions worth $428B, up 16% from $369B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $17.2B of net new capital in Q4 2023, opening 467 new positions and adding to 4,112 existing holdings. Its largest new stake was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was PepsiCo, an estimated $806M trimmed.
- Royal Bank of Canada's largest Q4 2023 buy was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $8.75B increase.
- Royal Bank of Canada's biggest Q4 2023 reduction was PepsiCo, cutting an estimated $806M.
- Royal Bank of Canada fully exited Activision Blizzard in Q4 2023, selling an estimated $69.3M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $428B portfolio in Q4 2023.
- Royal Bank of Canada opened 467 new positions and closed 401 in Q4 2023.
- Royal Bank of Canada's portfolio value rose 16% quarter-over-quarter to $428B.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.